Elutia (ELUT) Net Margin Growth (1y) (2020 - 2026)
Elutia (ELUT) Net Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -860.00 |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 469.00 |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 92.00 |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -777.00 |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 350.00 |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 85.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -81.00 |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 67.00 |
| 10 | Elutia | 40.24 Mn | 20.35 Mn | 1.45 Mn | 3,480.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14,692.00 |
| Dec 31, 2025 | -105,820.00 |
| Sep 30, 2025 | -14,554.00 |
| Jun 30, 2025 | 29,450.00 |
| Mar 31, 2025 | 13,553.00 |
| Dec 31, 2024 | 181,181.00 |
| Sep 30, 2024 | 18,822.00 |
| Jun 30, 2024 | -32,623.00 |
| Mar 31, 2024 | -11,579.00 |
| Dec 31, 2023 | -13,711.00 |
| Sep 30, 2023 | 2,948.00 |
| Jun 30, 2023 | -4,735.00 |
| Mar 31, 2023 | -8,213.00 |
| Dec 31, 2022 | 87.00 |
| Sep 30, 2022 | -11,615.00 |
| Jun 30, 2022 | -5,475.00 |
| Mar 31, 2022 | -3,156.00 |
| Dec 31, 2021 | -4,049.00 |
| Sep 30, 2021 | 1,457.00 |
| Jun 30, 2021 | 4,074.00 |